Related Experiment Video
Updated: Aug 16, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Staphylococcus aureus septicaemia in a patient with cystic fibrosis
C C Aebischer1, C Aebi, M H Schöni
1Department of Paediatrics, University of Berne, Inselspital, Switzerland.
Insights
Systemic steroid therapy for allergic bronchopulmonary aspergillosis can increase the risk of rare, life-threatening Staphylococcus aureus bacterial infections in cystic fibrosis patients. Prompt antibiotic treatment is crucial for recovery.
Area of Science:
- Medical Microbiology
- Pulmonology
- Immunology
Background:
- Cystic fibrosis (CF) patients commonly experience bacterial colonization of the bronchi.
- Infections extending beyond the lungs are rare in CF patients, particularly systemic bacterial infections.
- Allergic bronchopulmonary aspergillosis (ABPA) is a known complication in CF, often treated with corticosteroids.
Observation:
- A 12-year-old boy with CF developed pneumonia and Staphylococcus aureus (S. aureus) septicaemia while on oral corticosteroids for ABPA.
- The patient received a combination of antibiotics including flucloxacillin, ticarcillin-clavulanate, aztreonam, cefazolin, and rifampin, guided by S. aureus resistance testing.
- Recovery was achieved by day 25 of treatment.
Findings:
- Systemic corticosteroid use in ABPA may predispose CF patients to severe, invasive bacterial infections.
- Staphylococcus aureus can cause life-threatening pneumonia and septicaemia in this context.
- Antibiotic resistance patterns are critical for guiding effective treatment of S. aureus infections in CF.
Implications:
- Clinicians should consider the risk of systemic bacterial infections when prescribing corticosteroids for ABPA in CF patients.
- Vigilance for invasive bacterial infections is warranted in CF patients undergoing immunosuppressive therapy.
- This case highlights the importance of tailored antibiotic therapy based on susceptibility testing for severe S. aureus infections in CF.
Unlabelled:
Although bacterial colonisation of bronchi may occur from early childhood onwards, infections extending beyond the lungs are uncommon in patients with cystic fibrosis. A 12-year-old boy with cystic fibrosis, receiving oral corticosteroids for 3 weeks because of allergic bronchopulmonary aspergillosis, experienced pneumonia and septicaemia caused by Staphylococcus aureus. He was treated with flucloxacillin, ticarcillin-clavulanate, aztreonam, cefazolin and rifampin according to resistance testing of S. aureus cultured from the blood. On day 25 the patient finally had recovered.
Conclusion:
Systemic steroid therapy for allergic bronchopulmonary aspergillosis may favour life-threatening systemic bacterial infection which is rare in the immunocompetent patient with cystic fibrosis.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Cryptococcal Meningitis
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction

